Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Garrett M. Frampton
ResearcherPublications, citations & collaboration network
Garrett M. Frampton is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 674 works, 44,490 citations, an h-index of 86 and an i10-index of 180.
674
Works
44,490
Citations
86
h-index
180
i10-index
How has Garrett M. Frampton's publication output changed over time?
ScholarIQpublication output · 2008–2020
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2020.
1
1
1
1
1
2
1
2
1
1
2008201020112012201320152016201720182020
What are the most-cited papers on Garrett M. Frampton?
ScholarIQmost cited works
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton, Albert W. Cheng, G. Grant Welstead, Tristan Kooistra, Bryce W. Carey, Eveline J. Steine, Jacob H. Hanna, Michael A. Lodato, Garrett M. Frampton, Phillip A. Sharp, Laurie A. Boyer, Richard A. Young, Rudolf Jaenisch
Proceedings of the National Academy of Sciences. 20104,597 CitationsOPEN ACCESS
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
S149201819. 20173,771 CitationsOPEN ACCESS
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
The Lancet. 20163,735 Citations
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
S48437117. 20172,408 CitationsOPEN ACCESS
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Kai Wang, Sean R. Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M. Sanford, Peter An, James Sun, Frank Juhn, Kristina Brennan, Kiel Iwanik, Ashley Maillet, Jamie Buell, Emily White, Mandy Zhao, Sohail Balasubramanian, Selmira Terzic, Tina Richards, Vera Banning, Lázaro Ibrahim Romero García, Kristen Mahoney, Zac Zwirko, Amy Donahue, Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin, Snjezana Doğan, Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky
S106963461. 20132,210 CitationsOPEN ACCESS
Related on ScholarIQ
Boston Foundation
Institution
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Paper
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Paper
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Paper
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Paper
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Paper